Mineralocorticoid Action: Target Tissue Specificity Is Enzyme, Not Receptor, Mediated
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Mineralocorticoid receptors, both when in tissue extracts and when recombinant-derived, have equal affinity for the physiological mineralocorticoid aldosterone and for the glucocorticoids cortisol and corticosterone, which circulate at much higher concentrations than aldosterone. Such receptors are found in physiological mineralocorticoid target tissues (kidney, parotid, and colon) and in nontarget tissues such as hippocampus and heart. In mineralocorticoid target tissues the receptors are selective for aldosterone in vivo because of the presence of the enzyme 11 β-hydroxy-steroid dehydrogenase, which converts cortisol and corticosterone, but not aldosterone, to their 11-keto analogs. These analogs cannot bind to mineralocorticoid receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In mineralocorticoid-responsive tissues such as the kidney, cortisol is enzymatically converted to cortisone, a metabolically inactive steroid (569).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [569]
In the citing paper
“Thus, the type 2 enzyme inactivates the mineralocorticoid activity of cortisol in the kidney tubule (569), and inactivating mutations in the type 2 enzyme cause a syndrome of apparent mineralocorticoid excess (AME) (588).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [569]
In the citing paper
“Thus, 11HSD2 prevents cortisol from overwhelming renal mineralocorticoid receptors (569), and in the placenta and other fetal tissues 11HSD2 (583, 584) also inactivates cortisol.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [569]
In the citing paper
“The kidney has high levels of HSD11B2 activity which protects the mineralocorticoid receptor from activation by cortisol by inactivating it to cortisone (Edwards and Stewart, 1991, Funder et al., 1988).”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Funder et al., 1988
Citations
Cites
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946
Stewart, P., Valentino, R., Wallace, A. M., Burt, D., Shackleton, C. L., & Edwards, C. W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91014-2 · Cited by 803
Krozowski, Z. S., & Funder, J. W. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.19.6056 · Cited by 523
Self-citationThe Roles of Plasma Binding and Receptor Specificity in the Mineralocorticoid Action of Aldosterone1
FUNDER, J. W., FELDMAN, D., & EDELMAN, I. S. (1973) · Endocrinology · doi:10.1210/endo-92-4-994 · Cited by 232
Self-citationCharacterization of Rat Brain Aldosterone Receptors Reveals High Affinity for Corticosterone
BEAUMONT, K., & FANESTIL, D. D. (1983) · Endocrinology · doi:10.1210/endo-113-6-2043 · Cited by 193
Pearson Murphy, B. E. (1981) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(81)90226-0 · Cited by 178
Glucocorticoid Receptors in Rat Kidney: The Rinding of Tritiated-Dexamethasone1
FUNDER, J. W., FELDMAN, D., & EDELMAN, I. S. (1973) · Endocrinology · doi:10.1210/endo-92-4-1005 · Cited by 173
Self-citationAFFINITY OF LIQUORICE DERIVATIVES FOR MINERALOCORTICOID AND GLUCOCORTICOID RECEPTORS
Armanini, D., Karbowiak, I., & Funder, J. W. (1983) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1983.tb00038.x · Cited by 163
Self-citationGlucocorticoid and mineralocorticoid receptors for aldosterone
Rousseau, G. G., Baxter, J. D., Funder, J. W., Edelman, I. S., & Tomkins, G. M. (1972) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(72)90053-2 · Cited by 151
Self-citation
Research works printed but not linked: 4
- Krozowski, Z. S., Proceedings of the National Academy of Sciences of the United States of America 80: 6056 (1983).
- SHEPPARD, K, MINERALOCORTICOID SPECIFICITY OF RENAL TYPE-I RECEPTORS - INVIVO BINDING-STUDIES, AMERICAN JOURNAL OF PHYSIOLOGY 252: E224 (1987).
- SHEPPARD, K, TYPE-I RECEPTORS IN PAROTID, COLON, AND PITUITARY ARE ALDOSTERONE SELECTIVE INVIVO, AMERICAN JOURNAL OF PHYSIOLOGY 253: E467 (1987).
- STEWART, P.M., CORTICOSTEROIDS PEPT 39: 163 (1987).
Cited by
Items 601–700 of 1,001
Cortisol as a mineralocorticoid in human disease
Stewart, P. M. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00072-2 · Cited by 49
Characterization of 11β-HSD1B gene expression and enzymatic activity
Mercer, W., Obeyesekere, V. R., Smith, R., & Krozowski, Z. S. (1993) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(93)90015-c · Cited by 49
Self-citationGlucocorticoid Receptor β: View II
Carlstedt‐Duke, J. (1999) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(99)00178-2 · Cited by 49
Thompson, A., Han, V. K. M., & Yang, K. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2003.12.014 · Cited by 48
The Role of Aldosterone and Mineralocorticoid Receptors in Cardiovascular Disease
Funder, J. W. (2007) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200707030-00001 · Cited by 48
Self-citationLam, E. Y. M., Funder, J. W., Nikolic‐Paterson, D. J., Fuller, P. J., & Young, M. J. (2006) · Endocrinology · doi:10.1210/en.2005-1527 · Cited by 48
Self-citationExpression of 11β-Hydroxylase in Rat Leydig Cells
Wang, G.-M., Ge, R.-S., Latif, S. A., Morris, D. J., & Hardy, M. P. (2002) · Endocrinology · doi:10.1210/endo.143.2.8638 · Cited by 44
Enzymology and Molecular Biology of Glucocorticoid Metabolism in Humans
Blum, A., & Maser, E. (2003) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(03)75006-5 · Cited by 48
Sex- and tissue- specific regulation of 11β-hydroxysteroid dehydrogenase mRNA
Albiston, A. L., Smith, R. E., & Krozowski, Z. S. (1995) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(95)03501-w · Cited by 48
Self-citationImmunohistochemical distribution of 11β-hydroxysteroid dehydrogenase in human eye
SUZUKI, T. A., Sasano, H., Kaneko, C., Ogawa, S. A., Darnel, A. D., & Krozowski, Z. S. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00403-2 · Cited by 48
Yang, K., Khalil, M. W., Strutt, B. J., & KILLINGER, D. W. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(96)00187-2 · Cited by 48
The Hypothalamic-Pituitary-Adrenal—Immune Axis: A Critical Assessment
Lilly, M. P. (1992) · Archives of Surgery · doi:10.1001/archsurg.1992.01420120097017 · Cited by 46
Sheppard, K. E., Roberts, J. L., & Blum, M. (1990) · Endocrinology · doi:10.1210/endo-127-1-431 · Cited by 48
Aldosterone: A cardiovascular risk factor?
Funder, J. W., & Reincke, M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.08.005 · Cited by 47
“It was initially thought [19], and is still commonly taught, that 11β-hydroxysteroid dehydrogenase operates by excluding glucocorticoids from protected mineralocorticoid receptors via conversion to receptor-inactive 11-keto congeners (e.”
BackgroundSelf-citationSelvaraj, J., Sathish, S., Mayilvanan, C., & Balasubramanian, K. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1452-2 · Cited by 47
The development and SAR of pyrrolidine carboxamide 11β-HSD1 inhibitors
Cheng, H., Hoffman, J. E., Le, P., Nair, S. K., Cripps, S. J., Matthews, J. J., Smith, C. S., Yang, M. L., Kupchinsky, S., Dress, K. R., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.03.032 · Cited by 47
11β-HSD1, Inflammation, Metabolic Disease and Age-related Cognitive (dys)Function
Chapman, K. E., & Seckl, J. R. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9504-9 · Cited by 47
Meyer, T., & Wirtz, P. H. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7186 · Cited by 47
Gut feelings about bacterial steroid-17,20-desmolase
Ly, L. K., Doden, H. L., & Ridlon, J. M. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111174 · Cited by 47
Spironolactone in congestive heart failure
Soberman, J. E., & Weber, K. T. (2000) · Current Hypertension Reports · doi:10.1007/s11906-000-0027-x · Cited by 47
Baker, R. J., Walker, B. R., SHAW, R. J., Honour, J. W., Jessop, D. S., Lightman, S. L., Zumla, A. I., & Rook, G. A. W. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.5.9912119 · Cited by 47
Stewart, P. M., & Sheppard, M. C. (1992) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(92)90149-z · Cited by 47
11β‐Hydroxysteroid dehydrogenase and the brain: Not (yet) lost in translation
Seckl, J. R. (2023) · Journal of Internal Medicine · doi:10.1111/joim.13741 · Cited by 47
Nagase, M. (2010) · Clinical and Experimental Nephrology · doi:10.1007/s10157-010-0298-8 · Cited by 46
“In the Na-transporting epithelia, such as the renal distal nephron, the enzyme 11b-hydroxysteroid dehydrogenase type 2 (11bHSD2) confers specificity on aldosterone to activate MR, by converting cortisol and corticosterone into inactive 11-keto derivatives, which have low affinity for MR [21].”
BackgroundKonishi, A., Tazawa, C., Miki, Y., Darnel, A. D., SUZUKI, T. A., Ohta, Y., Suzuki, T., Tabayashi, K., & Sasano, H. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00198-5 · Cited by 46
New biology of aldosterone, and experimental studies on the selective aldosterone blocker eplerenone
Funder, J. W. (2002) · American Heart Journal · doi:10.1067/mhj.2002.129971 · Cited by 46
Self-citationEffect of central amiloride infusion on mineralocorticoid hypertension
Gómez-Sánchez, E. P., & Gómez-Sánchez, C. E. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.267.5.e754 · Cited by 46
Michael, A. E., Gregory, L., Piercy, E. C., Walker, S. M., Shaw, R. W., & COOKE, B. A. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57798-x · Cited by 46
Type I (mineralocorticoid) receptors in the guinea pig
Myles, K., & Funder, J. W. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.267.2.e268 · Cited by 46
Self-citationMiller, A. H., Spencer, R. L., Pearce, B. D., Pisell, T. L., Tanapat, P., Leung, J. J., Dhabhar, F. S., McEwen, B. S., & Biron, C. A. (1997) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(97)00028-0 · Cited by 46
Rijnberk, A., & Mol, J. A. (1997) · Elsevier eBooks · doi:10.1016/b978-012396305-5/50021-x · Cited by 46
Adipose tissue in cortisol excess: What Cushing’s syndrome can teach us?
Bavaresco, A., Mazzeo, P., Lazzara, M., & Barbot, M. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116137 · Cited by 45
Mechanisms of Mineralocorticoid Receptor Signaling
Fuller, P. J., Yang, J., & Young, M. J. (2018) · Vitamins and hormones · doi:10.1016/bs.vh.2018.09.004 · Cited by 45
The Mineralocorticoid Receptor in Salt-Sensitive Hypertension and Renal Injury
Ayuzawa, N., & Fujita, T. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020071041 · Cited by 45
Corticosteroids, Heart Failure, and Hypertension: A Role for Immune Cells?
Shen, J., & Young, M. J. (2012) · Endocrinology · doi:10.1210/en.2012-1780 · Cited by 45
Pharmacological treatment of aldosterone excess
Deinum, J., Riksen, N. P., & Lenders, J. W. M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.07.006 · Cited by 45
Hormone-regulated transepithelial Na+transport in mammalian CCD cells requires SGK1 expression
Helms, M. N., Fejes‐Tóth, G., & Náray‐Fejes‐Tóth, A. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00299.2002 · Cited by 45
“In the absence of 11 -hydroxysteroid dehydrogenase-2 activity, glucocorticoids can also induce mineralocorticoid-like effects (11, 17, 19, 24).”
BackgroundSouness, G. W., & Morris, D. J. (1996) · Hypertension · doi:10.1161/01.hyp.27.3.421 · Cited by 45
Aldosterone inhibits HCO-3absorption via a nongenomic pathway in medullary thick ascending limb
Good, D. W., George, T., & Watts, B. A. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00133.2002 · Cited by 45
Baker, M. E. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90355-m · Cited by 45
Moisan, M., Seckl, J. R., Brett, L. P., Monder, C., Agarwal, A. K., White, P. C., & Edwards, C. R. W. (1990) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1990.tb00651.x · Cited by 45
Kitanaka, S., Katsumata, N., Tanae, A., Hibi, I., Takeyama, K.-I., Fuse, H., Kato, S., & Tanaka, T. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4455 · Cited by 38
̈hler, H. B., Perschel, F. H., & Hierholzer, K. (1991) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(91)90268-l · Cited by 45
Effects of steroid hormones and related compounds ongene transcription
King, R. J. B. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02895.x · Cited by 45
“of glucocorticoid and mineralocorticoid effects in the kidney, the presence of an enzyme, 1 Ib-hydroxy steroid dehydrogenase, capable of metabolizing glucocorticoids such as cortisol, but not mineralocorticoids like aldosterone, influences specificity ofeffect (Funder et al., 1988; Edwards et al., 1989).”
BackgroundRole of Endogenous Glucocorticoids in Immune System Function: Regulation and Counterregulation
Spencer, R. L., Kalman, B. A., & Dhabhar, F. S. (2001) · Wiley eBooks · doi:10.1002/cphy.cp070418 · Cited by 45
Meaney, M. J., O’Donnell, D., Viau, V., Bhatnagar, S., Sarrieau, A., Smythe, J. W., Shanks, N. M., & Walker, C. (1993) · Springer eBooks · doi:10.1007/978-94-011-1540-7_10 · Cited by 45
Li, K. X. Z., Obeyesekere, V. R., Krozowski, Z. S., & Ferrari, P. (1997) · Endocrinology · doi:10.1210/endo.138.7.5232 · Cited by 44
Darnel, A. D., Archer, T. K., & Yang, K. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00116-8 · Cited by 44
Ghaemmaghami, P., Marca, R. L., Dainese, S. M., Haller, M., Zimmermann, R., & Ehlert, U. (2013) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2013.08.010 · Cited by 44
“This is important since circulating cortisol is 100 to 1000 times more abundant than the principal mineralocorticoid aldosterone [62].”
BackgroundAldosterone and mineralocorticoid receptors: A personal reflection
Funder, J. W. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.11.026 · Cited by 44
“…in epithelial cells, converts cortisol/corticosterone to their receptor-inactive 11-keto congeners, thus allowing aldosterone (in which the 11-hydroxyl group is protected by cyclization with the aldehyde group on carbon 18) to occupy and activate MR (Funder et al., 1988; Edwards et al., 1988).”
BackgroundSelf-citationHereditary Renal Tubular Disorders
Chadha, V., & Alon, U. S. (2009) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2009.03.013 · Cited by 44
Fumoto, T., Ishii, K., Ito, M., Berger, S., Schütz, G., & Ikeda, K. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.03.149 · Cited by 44
Regulation of 11β-Hydroxysteroid Dehydrogenase Type 2 by MicroRNA
Rezaei, M., Andrieu, T., Neuenschwander, S., Bruggmann, R., Mordasini, D., Frey, F. J., Vogt, B., & Frey, B. M. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.00002 · Cited by 44
“The enzyme exhibits a cell-specific expression in mineralocorticoid target tissues, such as epithelial cells from colon and cortical collecting tubules (CCD), where its main function is to protect the nonselective mineralocorticoid receptor from activation by cortisol in humans and by corticosterone in rodents.(2,3) A…”
BackgroundCorticosteroids Are Essential for Maintaining Cardiovascular Function in Male Mice
Cruz‐Topete, D., Myers, P., Foley, J. F., Willis, M. S., & Cidlowski, J. A. (2016) · Endocrinology · doi:10.1210/en.2015-1604 · Cited by 44
“Mineralocorticoids (aldosterone) are released by the adrenal gland in response to low blood volume or sodium depletion to regulate blood pressure (BP) (3).”
BackgroundImpaired Cortisol Binding to Glucocorticoid Receptors in Hypertensive Patients
Mulatero, P., Panarelli, M., Schiavone, D., Rossi, A., Mengozzi, G., Kenyon, C. J., Chiandussi, L., & Veglio, F. (1997) · Hypertension · doi:10.1161/01.hyp.30.5.1274 · Cited by 44
Nakamura, Y., Suzuki, S., Suzuki, T., Ono, K., Miura, I., Satoh, F., Moriya, T., Saito, H., Yamada, S., Ito, S., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051351 · Cited by 44
Dexamethasone Upregulates 11β-Hydroxysteroid Dehydrogenase Type 2 in BEAS-2B Cells
Suzuki, S., Koyama, K., Darnel, A. D., Ishibashi, H., Kobayashi, S., Kubo, H., Suzuki, T., Sasano, H., & Krozowski, Z. S. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1139oc · Cited by 44
11β-Hydroxysteroid dehydrogenase activity and corticosteroid hormone action
Stewart, P. M., & Whorwood, C. B. (1994) · Steroids · doi:10.1016/0039-128x(94)90082-5 · Cited by 44
Aromatase-Deficient (ArKO) Mice Have Reduced Blood Pressure and Baroreflex Sensitivity
Head, G. A., Obeyesekere, V. R., Jones, M. E., Simpson, E. R., & Krozowski, Z. S. (2004) · Endocrinology · doi:10.1210/en.2004-0421 · Cited by 40
Ueda, K., Nishimoto, M., Hirohama, D., Ayuzawa, N., Kawarazaki, W., Watanabe, A., Shimosawa, T., Loffing, J., Zhang, M.-Z., Marumo, T., et al. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08966 · Cited by 44
The role of 11β-hydroxysteroid dehydrogenase in steroid hormone specificity
Náray‐Fejes‐Tóth, A., Colombowala, I. K., & Fejes‐Tóth, G. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(98)00009-0 · Cited by 43
Gómez-Sánchez, E. P., Ganjam, V. K., Chen, Y. J., Cox, D. L., Zhou, M.-Y., Thanigaraj, S., & Gómez-Sánchez, C. E. (1997) · Steroids · doi:10.1016/s0039-128x(97)00011-1 · Cited by 43
Takeda, Y., Miyamori, I., Yoneda, T., Iki, K., Hatakeyama, H., & Takeda, R. (1994) · Hypertension · doi:10.1161/01.hyp.23.5.577 · Cited by 43
“The bioactivity of 11/3-hydroxysteroid dehydrogenase (11/3-HSD) has been identified in homogenates not only from rat liver and kidney but also from rat aorta and mesenteric artery.(1) A physiological role for 11/3-HSD has recently been suggested in the kidney, where it protects mineralocorticoid receptors from exposur…”
BackgroundAgarwal, A. K., Mune, T., Monder, C., & White, P. C. (1995) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(95)00005-f · Cited by 43
Alfaidy, N., Blot-Chabaud, M., Bonvalet, J. P., & Farman, N. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119785 · Cited by 36
Sakamoto, T., Mori, C., Minami, S., Takahashi, H., Abe, T., Ojima, D., Ogoshi, M., & Sakamoto, H. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.06.002 · Cited by 42
Renal medullary 11β-hydroxysteroid dehydrogenase type 1 in Dahl salt-sensitive hypertension
Liu, Y. U., Singh, R. J., Usa, K., Netzel, B. C., & Liang, M. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.90283.2008 · Cited by 42
Drug-induced endocrine blood pressure elevation
Beck, K. R., Thompson, G. R., & Odermatt, A. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104311 · Cited by 42
Holappa, M., Vapaatalo, H., & Vaajanen, A. (2020) · Annals of Medicine · doi:10.1080/07853890.2020.1758341 · Cited by 42
“However, another endogenous ligand, cortisol, binds to MR with much higher affinity than aldosterone [99].”
BackgroundSurgically correctable hypertension caused by primary aldosteronism
Rossi, G. P. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.07.003 · Cited by 42
Steigerwalt, S. P., Zafar, A., Mesiha, N., Gardin, J. M., & Provenzano, R. (2007) · American Journal of Nephrology · doi:10.1159/000100106 · Cited by 42
“Although the traditional site of action of aldosterone is on the mineralocorticoid receptor (MR) in the epithelium of the distal nephron, colon, and rectum, receptors have also been detected on nonepithelial sites in blood vessels, brain, and heart [”
BackgroundEnzyme-assisted synthesis and characterization of glucuronide conjugates of neuroactive steroids
Jäntti, S. E., Kiriazis, A., Reinilä, R., Kostiainen, R. K., & Ketola, R. A. (2007) · Steroids · doi:10.1016/j.steroids.2006.11.023 · Cited by 42
Yamashita, K., Nakagawa, R., Okuyama, M., Honma, S., Takahashi, M., & Numazawa, M. (2008) · Steroids · doi:10.1016/j.steroids.2008.02.009 · Cited by 42
11 -Hydroxysteroid Dehydrogenase Type 2 Is Expressed in the Human Kidney Glomerulus
Kataoka, S., Kudo, A., Hirano, H., Kawakami, H., Kawano, T., Higashihara, E., Tanaka, H., Delarue, F., Sraer, J., Mune, T., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8257 · Cited by 42
Tissue‐specific dysregulation of cortisol metabolism in equine laminitis
Johnson, P. J., Ganjam, V. K., Slight, S. H., Kreeger, J. M., & Messer, N. T. (2004) · Equine Veterinary Journal · doi:10.2746/0425164044864750 · Cited by 42
Glucocorticoids modulate baroreflex control of renal sympathetic nerve activity
Scheuer, D. A., & Mifflin, S. W. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.280.5.r1440 · Cited by 42
“In the periphery, aldosterone is the endogenous ligand for the type I receptor because of the presence of an enzyme (11b-hydroxysteroid dehydrogenase) that metabolizes cort and cortisol to inactive compounds (10, 26).”
BackgroundCardiac Synthesis of Aldosterone: Going, Going, Gone… ?
Funder, J. W. (2004) · Endocrinology · doi:10.1210/en.2004-1057 · Cited by 36
Self-citation7 11β-hydroxysteroid dehydrogenase
Stewart, P. M. (1994) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80257-5 · Cited by 41
Kim, S. W., Schou, U. K., Peters, C. D., de Seigneux, S., Kwon, T., Knepper, M. A., Jonassen, T. E. N., Frøkiær, J., & Nielsen, S. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080721 · Cited by 42
Vivanco, M. D., Johnson, R. S., Galante, P. E., Hanahan, D., & Yamamoto, K. R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07216.x · Cited by 42
Adrenal Steroid Effects on the Brain: Versatile Hormones with Good and Bad Effects
McEwen, B. S., Sakai, R. R., & Spencer, R. L. (1993) · Elsevier eBooks · doi:10.1016/b978-0-12-631330-7.50014-9 · Cited by 41
Maser, E. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01090-0 · Cited by 42
Цейликман, В. Э., Dremencov, E., Tseilikman, O. B., Pavlovičová, M., Lacinová, Ľ., & Ježová, D. (2019) · Stress · doi:10.1080/10253890.2019.1641080 · Cited by 41
Glucocorticoids act in the dorsal hindbrain to increase arterial pressure
Scheuer, D. A., Bechtold, A. G., Shank, S. S., & Akana, S. F. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00824.2003 · Cited by 39
“11 -Hydroxysteroid dehydrogenase 2, an enzyme that limits the access of Cort to MRs by metabolizing Cort (15), is present in the NTS but does not appear to be entirely colocalized with MRs (39, 40).”
BackgroundSpironolactone Prevents Aldosterone Induced Increased Duration of Atrial Fibrillation in Rat
Lammers, C., Dartsch, T., Brandt, M. C., Rottländer, D., Halbach, M., Peinkofer, G., Ockenpoehler, S., Weiergräber, M., Schneider, T., Reuter, H., et al. (2012) · Cellular Physiology and Biochemistry · doi:10.1159/000178483 · Cited by 41
Koyama, K., Myles, K., Smith, R., & Krozowski, Z. S. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00157-6 · Cited by 41
Self-citationCellular pharmacodynamics of immunosuppressive drugs for individualized medicine
Hirano, T. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.09.020 · Cited by 41
Roshan, A., Kumar, C. S., Singh, D. P., & Chandra, V. (2012) · International Research Journal of Pharmacy · Cited by 41
Renal mineralocorticoid receptor and electrolyte homeostasis
Terker, A. S., & Ellison, D. H. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00135.2015 · Cited by 41
Steroids - From Physiology to Clinical Medicine
Ostojić, S. M. (2012) · InTech eBooks · doi:10.5772/46119 · Cited by 41
“Endometrial SULT1E1 levels are influenced by the stage of pregnancy and by the menstrual cycle [41, 42].”
BackgroundIn Vivo Footprinting of the Human 11β-Hydroxysteroid Dehydrogenase Type 2 Promoter
Nawrocki, A. R., Goldring, C. E., Kostadinova, R. M., Frey, F. J., & Frey, B. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111549200 · Cited by 41
Bossis, I., Nishimura, S., Muchow, M., & Porter, T. E. (2004) · Endocrinology · doi:10.1210/en.2004-0155 · Cited by 41
Krozowski, Z. S., Albiston, A. L., Obeyesekere, V. R., Andrews, R. K., & Smith, R. E. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00194-8 · Cited by 41
Self-citationKornel, L. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90142-j · Cited by 41
Molecular basis for the Apparent Mineralocorticoid Excess Syndrome in the Oman population
Quinkler, M. O., Bappal, B., Draper, N. R., Atterbury, A., Lavery, G. G., Walker, E. A., Desilva, V. R., Taylor, N., Hala, S., Rajendra, N., et al. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.019 · Cited by 41
Gómez-Sánchez, E. P., Cox, D. S., Foecking, M. F., Ganjam, V. K., & Gómez-Sánchez, C. E. (1996) · Steroids · doi:10.1016/0039-128x(95)00201-z · Cited by 41
Metabolism of Corticosterone in Mammalian and Avian Intestine
Vylitová, M., Mikšík, I., & Pácha, J. (1998) · General and Comparative Endocrinology · doi:10.1006/gcen.1997.7035 · Cited by 41
Expression of the 11β-hydroxysteroid dehydrogenase 2 gene in the mouse
Moore, X., Hoong, I., & Cole, T. J. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00967.x · Cited by 40
Regulation of NaCl transport in the renal collecting duct: lessons from cultured cells
Bens, M., Chassin, C., & Vandewalle, A. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0123-0 · Cited by 40
“Consistent with the presence of type 2 11β-hydroxysteroid dehydrogenase (11βHSD2), which metabolizes glucocorticoids to form inactive 11-dehydroderivatives [32, 40 ], carbenoxolone potentiates the corticosterone-stimulated Isc [7].”
Background
Metadata
- Authors
- Funder, J. W., Pearce, P. T., Smith, R., & Smith, A. I.
- Affiliations
- Medical Research Centre, Prince Henry's Hospital, Melbourne, Australia 3004.
- Venue
- Science
- Published
- 1988-10-28
- Volume
- 242
- Issue
- 4878
- Pages
- 583-585
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2148114970
- Semantic Scholar
- ae47dabb539e84fc85ea0bfd3f1a669037f37264
- Cited by
- 1,628
- References
- 19
- Citations by year
- 2026: 15 · 2025: 7 · 2024: 21 · 2023: 21 · 2022: 16 · 2021: 25 · 2020: 25 · 2019: 32 · 2018: 32 · 2017: 33 · 2016: 26 · 2015: 30 · 2014: 37 · 2013: 44 · 2012: 56
- FWCI
- 30.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- mineralocorticoid receptor, aldosterone, glucocorticoids, cortisol, corticosterone, 11β-hydroxysteroid dehydrogenase, 11-keto steroids, kidney, parotid gland, colon, hippocampus, heart
- MeSH terms
- Adrenalectomy, Aldosterone, Animals, Carbenoxolone, Colon, Corticosterone, Heart, Hippocampus, Hydrocortisone, Hydroxysteroid Dehydrogenases, Kidney, Parotid Gland, Receptors, Steroid, Receptors, Mineralocorticoid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.